Skip navigation.
Cappolino, Dodd, Krebs, LLP

www.AsbestosLaw.com

No Fee Until We Win
1-(888)-MESO-FIRM

1-(888)-637-6347

Servicing Clients Nationwide

Rss Feed Twitter Link Facebook Link Linked In Link

Posts Tagged ‘asbestos fibers’

Asbestos Causes More Diseases Than Just Mesothelioma

Monday, May 2nd, 2011

According to Asbestos, the toxic mineral can cause illnesses other than mesothelioma. It is known that asbestos exposure is the main cause of development of mesothelioma and asbestosis, however, it may lead to development of other pulmonary diseases.

A 79-year-old man was recently diagnosed with chronic obtrusive pulmonary disease, according to syndicated “To Your Health” column by Dr. Paul Donohue. The diseases is made up of emphysema and chronic bronchitis, often showing itself as a smoker’s sickness. However, the main in question had never smoked tobacco.

The man did work with asbestos throughout his life. The doctor said the disease could have been caused by exposure to dangerous and toxic asbestos fibers. Dr. Donohue agreed with the assessment, saying the diagnosis may be linked to smoking but advancement in one’s age and exposure to asbestos have been found to be a cause of the illness as well. Air pollution, lung infections, exposure to dusts and other contaminants, and genetic illness are other causes of COPD.

Mesothelioma is commonly seen in individuals who have spent years working around asbestos and products manufactured with the use of asbestos. Asbestos fibers are inhaled and lodge themselves in the tissue surrounding the lungs, heart and the chest cavity. It may take decades for the first symptoms of an asbestos-related disease to appear. Advancement in age and late diagnosis usually mean an individual will receive a poor prognosis and life expectancy. Asbestos-related diseases are known as severe and may gravely affect a an individual’s qualify of life.

Mesothelioma Risk in Men On the Rise, According to Study

Tuesday, April 5th, 2011

According to About Mesothelioma, more than 20 million of Americans are at risk of developing malignant mesothelioma due to asbestos exposure. The figure comes from researchers at the University of Hawaii Cancer Center. A study published in the Journal of Cell Physiology suggests that malignant mesothelioma mortality rates will increase 5 to 10 percent per year in most countries until about 2020.

Approximately 3,000 people die each year in the U.S. of mesothelioma, a deadly type of cancer of the lining of the lung and abdomen caused by asbestos exposure. Asbestos was widely used in construction, auto industry and other building materials until it’s ban in the 1980s. Asbestos is still used in some products currently manufactured in the States and imported from other countries.

The scientists found that the incidence of malignant mesothelioma among men has continued to rise during the past 50 years, while incidence among women has not change. Men are most likely to be employed in a line of work that has a higher chance of asbestos exposure. Mesothelioma takes decades to show symptoms, which is another reason why it is difficult to treat. Asbestos fibers lodge in the lining of the heart and lungs, festering for at least 20 decades before showing a first symptom. Many workers are unaware of asbestos exposure until their later years.

Men employed in construction, demolition work, plumbing, auto industry and utility work are at a higher risk of asbestos exposure and mesothelioma than men in other lines of employment.

Jury Awards $9 Million in Asbestos Exposure Cancer Lawsuit

Tuesday, March 22nd, 2011

According to Business Wire, a jury awarded a verdict of $9 million in an asbestos exposure and cander to the family of Robert Henderson. The family, Henderson’s wife and daughters Adrienne and Za’Quoia, sued Dow Chemical for the deceased’s exposure to asbestos while working at the facility.

Family claimed that Henderson suffered from mesothelioma which came as a result of asbestos exposure at Dow Chemical. The plaintiffs’ attorney said the company knew Henderson could get cancer. Henderson spent much of his career working around asbestos-containing products as a contract employee at Dow Chemical. The plaintiff’s claimed Henderson’s exposure may have come from Down insulators which contained asbestos.

Dow Chemical headquartered in Midland, Michigan is one of the largest chemical manufacturers in the world by revenue and third-largest chemical company in the world by capitalization. Among its products, Dow providers plastics, chemicals and agricultural products. According to the plaintiff’s complaint, the company employs thousands of workers who may have been exposed to asbestos in the air.

Asbestos fibers are released from asbestos containing products such as Dow insulators. Asbestos fibers settle very slowly in the air and are a hazard when inhaled by workers. Individuals exposed to asbestos fibers have a higher risk of developing asbestos-related health issues and cancer. Mesothelioma is a cancer of the membranes that line the chest and lungs, caused by asbestos fibers which cause irreversible scarring of lung tissue. Lodged asbestos fibers remain in lungs, heart and surrounding tissue, and spend decades festering.

Dow Jones said it will seek an appeal of the jury verdict, while adding that the jury said Dow must pay 30% of damages in the case.

Thoracotomy May Aid Mesothelioma Subtype Diagnosis

Tuesday, February 15th, 2011

According to the Journal of Thoracic Oncology, new research suggests that a thoracotomy may be a good way to get an accurate mesothelioma subtype diagnosis. A thoracotomy is an open surgical biopsy.
Determining a subtype gives a patient a better prognostic indicator and is a good guide to determining treatment options. Mesothelioma subtypes are difficult to determine, which can delay effective treatment.

In the study, a group of Australian scientists evaluated the records of 83 mesothelioma patients who underwent an extra pleural pneumonectomy surgery between 1994 and 2009. The research panel examined specimens collected during the surgery and compared its subtypes to each patient’s initial subtype diagnosis. Prior to EPP, those patients underwent different methods of mesothelioma subtype diagnosis, including thoracoscopy, tomography biopsy and thoracotomy.

The researchers found that in the group one in five mesothelioma patients received inaccurate mesothelioma subtype diagnosis. Thoracotomy biopsies had best results, with 83% accuracies in subtype diagnosis. Thoracoscopy had second best results with 74% accuracy rate and tomography had only a 44% success rate.

A thoracotomy is an open biopsy that involves a large incision into the chest. However, the surgery makes it easier for surgeons to collect a large sample of malignant mesothelioma cells for testing and diagnosis purposes. As it is a surgical procedure, thoracotomy carries an increased risk of complications than other diagnostic methods. The researchers found that a larger specimens aids in accuracy of subtype classification.